Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$15M
8 rounds on record
Latest round
$15M
Venture round · Jun 2024 · 2 yr ago
Team
51-200
employees, estimated range
Grants
$4.8M
7 grants · CORDIS
The money's age
Long since its last round
28 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 17, 2024 Raised a round Venture round $15M · SEC Form D 2023 Founded May 1, 2022 Won a grant $2M · CORDIS Aug 10, 2020 Won a grant $1.6M · CORDIS Apr 15, 2020 Won a grant $427k · CORDIS Jul 1, 2019 Won a grant $200k · CORDIS Jun 20, 2019 Won a grant $100k · CORDIS Sep 17, 2018 Won a grant $225k · CORDIS Jan 1, 2018 Won a grant $225k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jun 2024 $15M — SEC Form D
Grant May 2022 $2M — CORDIS
Grant Aug 2020 $1.6M — CORDIS
Grant Apr 2020 $427k — CORDIS
Grant Jul 2019 $200k — CORDIS
Grant Jun 2019 $100k — CORDIS
Grant Sep 2018 $225k — CORDIS
Grant Jan 2018 $225k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity Primrose Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Helge ZielerDirector, Executive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Hexamer TherapeuticsVenture round $500k · 3 mo ago · 1-10 employees
Innovators in natural vaccine technology. Explore rapidly engineered, scalable vaccine technologies at Hexamer Therapeutics.
ReNewVax logoVenture round · 10 mo ago · Founded 2022
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
Base ImmuneVenture round · 12 mo ago · Founded 2019 · 11-50 employees
404 Err….or The vaccines you're looking for don't exist. Yet….
Animal Vaccine Delivery in Just 30 Minutes. Experience the world's fastest vaccine delivery. Get a complete range of vaccines delivered…
Liberum Bio builds cell-free reagents, protein discovery infrastructure, directed-evolution workflows, and vaccine manufacturing…
GIVAX51-200 employees
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…

Overview

Primrose Bio develops and commercializes manufacturing technologies that close gaps in biologics, mRNA and vaccine production.

People

Helge Zieler
Director, Executive Officer
Matthew Reber
Director
J. Mitchell
Director
Matthew Korenberg
Director
Wes Kaupinen
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego United States
HQ
Get in Touch
50-200 est. staff
10790 Roselle St,, San Diego, CA 92121
company site

Financials

Total raised
$19.8M
Latest round
Venture - Series Unknown
Funding rounds
8
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $15M Details
Grant 2022 $2M Details
Grant 2020 $1.6M Details
Grant 2020 $427k Details
Grant 2019 $200k Details
Grant 2019 $100k Details
Grant 2018 $225k Details
Grant 2018 $225k Details